Michael Newman

Fondatore presso INDAPTUS THERAPEUTICS, INC.

70 anni

Health Technology

Consumer Services

Profilo

Michael James Newman was the founder of Decoy Biosystems, Inc., founded in 2013, where the titles held included President, CEO, CFO, Secretary & Director from 2013 to 2021.
Dr. Newman is the founder of Indaptus Therapeutics, Inc., founded in 2021, holding the title of Chief Scientific Officer since 2021.
Former jobs include Executive Director-Oncology at Novartis Pharmaceuticals Corp.
from 1992 to 1997, Senior Associate Director at Sandoz Pharmaceuticals Corp., Director & Chief Scientific Officer at Intec Pharma Ltd., Executive Vice President-Oncology at Huyabio International LLC, Faculty at Brandeis University from 1984 to 1987, Executive Vice President-Oncology at Ontogen Corp., Executive Vice President-Research & Development at Vaxiion Therapeutics LLC, and Chief Scientific Officer & Vice President-Research at Dihedron Corp.
Education includes undergraduate studies at the University of California San Diego and a doctorate from Harvard Medical School.

Posizioni attive di Michael Newman

Società	Posizione	Inizio
INDAPTUS THERAPEUTICS, INC.	Fondatore	24/02/2021

Tutte le posizioni attive di Michael Newman

Precedenti posizioni note di Michael Newman

Società	Posizione	Fine
Decoy Biosystems, Inc. Decoy Biosystems, Inc. BiotechnologyHealth Technology Develops toll-like receptor against cancer and provides cancer immunotherapy services	Amministratore Delegato	01/08/2021
Novartis Pharmaceuticals Corp. Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions	Corporate Officer/Principal	01/01/1997
Brandeis University Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	01/01/1987
Intec Pharma Ltd. Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat neurodegenerative diseases	Direttore Tecnico/Scientifico/R&S	-
Huyabio International LLC Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Michael Newman

Formazione di Michael Newman

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Michael Newman

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	12
Huyabio International LLC Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products	Health Technology
Brandeis University Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of California San Diego University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Novartis Pharmaceuticals Corp. Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions	Health Technology
Ontogen Corp.
Sandoz Pharmaceuticals Corp.
Vaxiion Therapeutics, Inc. Vaxiion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company	Health Technology
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Dihedron Corp.
Intec Pharma Ltd. Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat neurodegenerative diseases	Health Technology
Decoy Biosystems, Inc. Decoy Biosystems, Inc. BiotechnologyHealth Technology Develops toll-like receptor against cancer and provides cancer immunotherapy services	Health Technology
Indaptus Therapeutics, Inc. Indaptus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Health Technology